icon-folder.gif   Conference Reports for NATAP  
 
  The International Liver Congress™
EASL 2017 - European Association for the
Study of the Liver
Amsterdam, The Netherlands. 2017
Back grey_arrow_rt.gif
 
 
 
DARING-B: Discontinuation of effective entecavir (ETV) or tenofovir (TDF) therapy in non-cirrhotic HBeAg-negative chronic hepatitis B (CHBe-) patients: a prospective Greek study
 
 
  Reported by Jules Levin
Reported by Jules Levin
EASL 2017 April 19-21 Amsterdam, Netherlands
 
George Papatheodoridis1, Eirini Rigopoulou2, Margarita Papatheodoridi1, Kalliopi Zachou2, Vasilis Xourafas1, Nikolaos Gatselis2, John Vlachogiannakos1, George Dalekos2
 
1Academic Department of Gastroenterology, Medical School of National and Kapodistrian University of Athens, Laiko General Hospital, Athens, Greece; 2Department of Medicine and Research Laboratory of Internal Medicine, Thessalia University Medical School, Larissa, Greece.

0425171

 

0425172

0425173

0425174

0425175

0425176